Minimally Processed Red Meat Can Work in Weight Loss Diet With Diabetes
High-protein, lean beef diet achieved similar weight loss, glucose control as normal-protein diet with no red meat.
Type 2 Diabetes Information Center
Tirzepatide Decreases Weight in Patients With Diabetes
A study was conducted to determine if tirzepatide therapy is safe and effective for weight reduction in patients with diabetes.
Depression in Type 2 Diabetes Increases All-Cause Mortality Risk
A study examined the effect of depression on cardiovascular and all-cause mortality in individuals with type 2 diabetes.
Home-Based Resistance Exercise Not Linked With Lower HbA1c in Type 2 Diabetes
Researchers examined the effect of a home-based resistance exercise regimen on glycated HbA1c levels, muscle strength, and body composition in individuals with type 2 diabetes.
Glucose-Lowering Medications Reduce CV Risk in Hispanic Patients With Diabetes
Researchers sought to examine the effect of glucose-lowering medications on cardiovascular and renal outcomes in Hispanic patients.
Heavy Alcohol Intake Linked to Obesity, Type 2 Diabetes
Genetic evidence does not support protective effects of modest alcohol consumption on obesity traits, T2D.
Clinical, Metabolic Factors Influence T2D Remission After Gastric Bypass
More than half of patients in remission 6 years after surgery, regardless of weight loss.
529 Million People Living With Diabetes Worldwide in 2021
More than 1.31 billion projected to have diabetes by 2050, with almost half of countries having age-standardized rate greater than 10%.
Basal-Only Insulin Delivery System Cleared for Patients With Type 2 Diabetes
Omnipod GO is a tubeless and waterproof insulin delivery system.
Glycemic Control Improved With Exercise in the Afternoon
Afternoon exercise group had greatest reduction in HbA1c at year 1 among adults with overweight or obesity and type 2 diabetes.
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
The FDA does not review compounded drugs for safety, effectiveness, or quality; compounded medications are not FDA-approved
Get Moving: Prescribing Exercise to End Insulin Resistance
Afternoon high intensity exercise may have a greater effect on lowering blood glucose levels in patients with diabetes than morning high intensity interval training.
Substantial Weight Loss Reductions Observed With Tirzepatide in T2D Patients
Tirzepatide is a once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.
Sugar-Sweetened Beverage Intake Linked to Mortality, CVD in T2D
Increased hazard ratio noted for all-cause mortality, CVD incidence and mortality for higher sugar-sweetened beverage intake.
Macrovascular Complication Is Unaffected by Glucose Control Intensity in Diabetes
Researchers investigated the role of glucose control on multiple cardiovascular disease-related events in patients with type 2 diabetes.
Greater HbA1c, Weight Loss Reductions Seen With Oral Semaglutide at Higher Doses
Novo Nordisk plans to file for regulatory approval of the 25mg and 50mg dosage strengths in 2023.
Semaglutide and Tirzepatide: Top 5 Things Clinicians Should Know
Obesity experts discuss how semaglutide and tirzepatide are changing the treatment landscape and challenges affecting access including drug shortages, inappropriate prescribing, insurance coverage, and cost.
More than 60% of Adults With Type 1 Diabetes Have Overweight, Obesity
Those with type 1 diabetes are least likely to increase physical activity, reduce caloric intake to manage overweight or obesity.
SGLT2 Inhibitor Use in Case of Acute Decompensated Heart Failure With Edema
Case demonstrates initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor in a patient with type 2 diabetes and heart failure.
We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...